Curoverse proudly sponsored the Codefest at BOSC 2014, which drew over 50 attendees from the open source bioinformatics community. Several members of our science and engineering teams attended and answered questions from the open source community. Attendees also received complimentary Curoverse beta accounts!

This week, Dr. Alexander (Sasha) Wait Zaranek, Curoverse’s chief scientist, spoke on a panel at the Personalized Medicine World Conference entitled, “Will bioinformatics scale?” Sasha was joined by Somalee Datta, Director of the Bioinformatics Core at the Stanford Center for Genomics and Personalized Medicine, and Jonathan Hirsch, Founder and President of Syapse.

HealthFoo, which took place on December 7th and 8th, featured an array of speakers from the healthcare and biomedical world, including our own scientific director, Alexander Wait Zaranek, also known as Sasha. Watch as Sasha explains the specific needs created by exabyte-scale biomedical data, all in five minutes.

We were delighted to see the press on our announcements yesterday regarding our funding, new name, open source project, and private beta. There were a number of great articles that really tell our story. Here are just a few:

For those of you who have been following our journey, you know that until today we’ve been called Clinical Future. Now we’re changing our name to Curoverse. Today, we’re also announcing our seed financing round, officially announcing the Arvados open source project, and beginning the private beta for our platform-as-a-service. Of course, there is more